Recurrent miscarriage is associated with increased ghrelin mRNA expression in the endometrium- a case-control study

Area of Science:

• Reproductive Endocrinology
• Molecular Biology
• Gynecology

Background:

• Ghrelin, a hormone, is present in the human endometrium.
• Ghrelin and its receptor are linked to the reproductive system.
• Ghrelin's association with angiogenesis (new blood vessel formation) is known.

Purpose of the Study:

• To compare mRNA expression of ghrelin, its receptor (GHS-R), vascular endothelial growth factor A (VEGF A), and its receptors (VEGFR1-3) in the endometrium.
• To investigate these expressions in women with recurrent miscarriage versus healthy controls.
• To explore correlations between gene expressions in both groups.

Main Methods:

• Case-control study design.
• Endometrial samples collected during the secretory phase.
• Quantitative reverse transcription polymerase chain reaction (RT-PCR) to analyze mRNA expression.

Main Results:

• Significantly higher mRNA expression of ghrelin and VEGF A in women with recurrent miscarriage compared to controls.
• In controls, ghrelin mRNA correlated positively with VEGF A and VEGFR1 mRNA.
• No significant correlations were found between these genes in the recurrent miscarriage group.

Conclusions:

• Increased endometrial ghrelin and VEGF A mRNA expression may be associated with recurrent miscarriage.
• Ghrelin might play a role in the underlying mechanisms of recurrent pregnancy loss.
• Further research is warranted to elucidate ghrelin's specific role in miscarriage pathogenesis.